Citations (33)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Shan Yang, Weidong Fei, Yunchun Zhao, Fengmei Wang, Yiqing Ye & Fenfen Wang. (2023) Combat Against Gynecological Cancers with Blood Vessels as Entry Point: Anti-Angiogenic Drugs, Clinical Trials and Pre-Clinical Nano-Delivery Platforms. International Journal of Nanomedicine 18, pages 3035-3046.
Read now
Read now
Xiaofeng Xu, Yuhua Yan, Qingying Xun, Jiayu Shi, Xiangyi Kong, Jun Wu & Huaijun Zhou. (2019) Combined silencing of VEGF-A and angiopoietin-2, a more effective way to inhibit the Ishikawa endometrial cancer cell line. OncoTargets and Therapy 12, pages 1215-1223.
Read now
Read now
Articles from other publishers (31)
Zhongmian Pan, Zhongbin Luo, Hongying He, Yujie Chen, Bingbing Zhao, Zhijun Yang & Li Li. (2023) Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer. Journal of Ovarian Research 16:1.
Crossref
Crossref
Juan A. Marín-Jiménez, Sandra García-Mulero, Xavier Matías-Guiu & Josep M. Piulats. (2022) Facts and Hopes in Immunotherapy of Endometrial Cancer. Clinical Cancer Research 28:22, pages 4849-4860.
Crossref
Crossref
X. Yang, H. Ren, Z. Li, L. Zhang, Y. Shao, H. Li, X. Yang, Y. Sun, X. Zhang, Z. Wang & J. Fu. (2022) A phase III randomized, controlled trial of nedaplatin versus cisplatin concurrent chemoradiotherapy in patients with cervical cancer. ESMO Open 7:5, pages 100565.
Crossref
Crossref
N. S. Zolotukhina & L. F. Gulyaeva. (2022) Prognostic value of angiogenic markers of endometrial cancer (literature review). Siberian journal of oncology 21:4, pages 137-146.
Crossref
Crossref
Qingli Cui, Yuefeng Mao, Yanhui Hu, Dongyang Ma & Huaimin Liu. (2022) Anlotinib in recurrent or metastatic endometrial cancer. International Journal of Gynecologic Cancer 32:9, pages 1147-1152.
Crossref
Crossref
Yu He, Lu Lin, Yurong Ou, Xiaowen Hu, Chi Xu & Caizhi Wang. (2022) Endothelial cell-specific molecule 1 (ESM1) promoted by transcription factor SPI1 acts as an oncogene to modulate the malignant phenotype of endometrial cancer. Open Medicine 17:1, pages 1376-1389.
Crossref
Crossref
Emine Kilinç & Abdulkadir Yasir Bahar. (2022) The Value of Intratumoral and Extratumoral Microvessel Density for the Tumor-dominated Area in the Endometrial Carcinoma. Applied Immunohistochemistry & Molecular Morphology 30:7, pages 501-508.
Crossref
Crossref
Shilin Wang, Guohong Liu, Yirong Li & Yunbao Pan. (2022) Metabolic Reprogramming Induces Macrophage Polarization in the Tumor Microenvironment. Frontiers in Immunology 13.
Crossref
Crossref
Chengwen Jin, Mingyuan Yuan, Hualei Bu & Chengjuan Jin. (2022) Antiangiogenic Strategies in Epithelial Ovarian Cancer: Mechanism, Resistance, and Combination Therapy. Journal of Oncology 2022, pages 1-15.
Crossref
Crossref
Lawrence Kasherman, Shiru (Lucy) Liu, Katherine Karakasis & Stephanie Lheureux. (2022) Angiogenesis: A Pivotal Therapeutic Target in the Drug Development of Gynecologic Cancers. Cancers 14:5, pages 1122.
Crossref
Crossref
Sudip Mukherjee & Vijay Sagar MadamsettySudip Mukherjee & Vijay Sagar Madamsetty. 2022. Nanoparticles in Angiogenesis and Cancer. Nanoparticles in Angiogenesis and Cancer
21
31
.
Luka Roškar, Irena Roškar, Tea Lanišnik Rižner & Špela Smrkolj. (2021) Diagnostic and Therapeutic Values of Angiogenic Factors in Endometrial Cancer. Biomolecules 12:1, pages 7.
Crossref
Crossref
Hongli Zhu, Qihui Cheng & Hong Cai. (2021) lncRNA-ZFAS1 promotes the progression of endometrial carcinoma by targeting miR-34b to regulate VEGFA expression. Open Medicine 16:1, pages 1472-1481.
Crossref
Crossref
Tiezhong Yi, Yicun Song, Lingling Zuo, Siyun Wang & Jintian Miao. (2021) LINC00470 Stimulates Methylation of PTEN to Facilitate the Progression of Endometrial Cancer by Recruiting DNMT3a Through MYC. Frontiers in Oncology 11.
Crossref
Crossref
Luka Roškar, Teja Klančič, Tamara Knific, Tea Lanišnik Rižner & Špela Smrkolj. (2021) Tie-2, G-CSF, and Leptin as Promising Diagnostic Biomarkers for Endometrial Cancer: A Pilot Study. Journal of Clinical Medicine 10:4, pages 765.
Crossref
Crossref
Thomas A. Paterniti, Evan A. Schrader, Aditi Talkad, Kasey Shepp, Jesse Wayson, Alexandra M. Poch & Sarfraz Ahmad. 2021. Overcoming Drug Resistance in Gynecologic Cancers. Overcoming Drug Resistance in Gynecologic Cancers
225
266
.
Xiangshang Xu, Li Li, Xiaolan Li, Deding Tao, Peng Zhang & Jianping Gong. (2020) Aptamer-protamine-siRNA nanoparticles in targeted therapy of ErbB3 positive breast cancer cells. International Journal of Pharmaceutics 590, pages 119963.
Crossref
Crossref
Robert Hoffmann, Sayantani Sarkar Bhattacharya, Debarshi Roy, Boris Winterhoff, Ralf Schmidmaier, Keith Dredge, Edward Hammond & Viji Shridhar. (2020) Sulfated glycolipid PG545 induces endoplasmic reticulum stress and augments autophagic flux by enhancing anticancer chemotherapy efficacy in endometrial cancer. Biochemical Pharmacology 178, pages 114003.
Crossref
Crossref
Tomasz Kluz, Tomasz Łoziński, Sylwia Czekierdowska, Norbert Stachowicz, Grzegorz Gurynowicz, Mieczysław Chróściel & Artur Czekierdowski. (2020) Tumor budding index and microvessel density assessment in patients with endometrial cancer: A pilot study. Oncology Letters 20:3, pages 2701-2710.
Crossref
Crossref
Lele Li, Manhui Zhu, Wenli Wu, Bai Qin, Jiayi Gu, Yuanyuan Tu, Jianing Chen, Dong Liu, Yunwei Shi, Xiaojuan Liu, Aimin Sang & Dongmei Ding. (2019) Brivanib, a multitargeted small‐molecule tyrosine kinase inhibitor, suppresses laser‐induced CNV in a mouse model of neovascular AMD. Journal of Cellular Physiology 235:2, pages 1259-1273.
Crossref
Crossref
Yixuan Cai, Yue Chang & Yun Liu. (2019) Multi-omics profiling reveals distinct microenvironment characterization of endometrial cancer. Biomedicine & Pharmacotherapy 118, pages 109244.
Crossref
Crossref
Hsiao-Chen Chiu, Chia-Jung Li, Giou-Teng Yiang, Andy Tsai & Meng-Yu Wu. (2019) Epithelial to Mesenchymal Transition and Cell Biology of Molecular Regulation in Endometrial Carcinogenesis. Journal of Clinical Medicine 8:4, pages 439.
Crossref
Crossref
Eunice Nyasani, Iqbal Munir, Mia Perez, Kimberly Payne & Salma Khan. (2018) Linking obesity-induced leptin-signaling pathways to common endocrine-related cancers in women. Endocrine 63:1, pages 3-17.
Crossref
Crossref
Christian Steinebach, Agnieszka Ambrożak, Stefan Dosa, Shaunna L. Beedie, Jonathan D. Strope, Gregor Schnakenburg, William D. Figg & Michael Gütschow. (2018) Synthesis, Structural Characterization, and Antiangiogenic Activity of Polyfluorinated Benzamides. ChemMedChem 13:19, pages 2080-2089.
Crossref
Crossref
Jian Zhang Wang, Yu Jing Xiong, Gene Chi Wai Man, Xiao Yan Chen, Joseph Kwong & Chi Chiu Wang. (2018) Clinicopathological and prognostic significance of blood microvessel density in endometrial cancer: a meta-analysis and subgroup analysis. Archives of Gynecology and Obstetrics 297:3, pages 731-740.
Crossref
Crossref
Tomislav Jocić & Milena Vuletić. (2018) Clinical significance of CD34 in endometrioid carcinoma of the uterine body. Materia medica 34:3, pages 1579-1586.
Crossref
Crossref
Jianzhang Wang, Gene Chi Wai Man, Tak Hang Chan, Joseph Kwong & Chi Chiu Wang. (2018) A prodrug of green tea polyphenol (–)-epigallocatechin-3-gallate (Pro-EGCG) serves as a novel angiogenesis inhibitor in endometrial cancer. Cancer Letters 412, pages 10-20.
Crossref
Crossref
Vicky Makker, Angela K. Green, Robert M. Wenham, David Mutch, Brittany Davidson & David Scott Miller. (2017) New therapies for advanced, recurrent, and metastatic endometrial cancers. Gynecologic Oncology Research and Practice 4:1.
Crossref
Crossref
Federica Tomao, Pierluigi Benedetti Panici & Silverio Tomao. (2017) Pembrolizumab in Programmed Death Ligand 1–Positive Endometrial Cancer. Journal of Clinical Oncology 35:31, pages 3633-3633.
Crossref
Crossref
Arthur-Quan Tran & Paola Gehrig. (2017) Recent Advances in Endometrial Cancer. F1000Research 6, pages 81.
Crossref
Crossref
Lucia Morbidelli. (2016) Polyphenol-based nutraceuticals for the control of angiogenesis: Analysis of the critical issues for human use. Pharmacological Research 111, pages 384-393.
Crossref
Crossref